PROCEPT BioRobotics (PRCT) Total Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Total Liabilities data on file, last reported at $139.4 million in Q1 2026.

• Quarterly Total Liabilities rose 7.05% year-over-year to $139.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139.4 million (up 7.05% YoY) and the FY2025 annual result came in at $142.2 million, up 7.9% from the prior year.
• Total Liabilities retreated to $139.4 million in Q1 2026 per PRCT's latest filing, from $142.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $142.2 million in Q4 2025 and bottomed at $68.2 million in Q1 2022.
• The 5-year median for Total Liabilities is $122.6 million (2024), against an average of $118.0 million.
• The widest annual swing landed in 2022, when Total Liabilities slumped 65.23%; it then jumped 63.33% in 2023.
• Tracing PRCT's Total Liabilities over 5 years: stood at $112.3 million in 2022, then rose by 10.43% to $124.0 million in 2023, then gained by 6.32% to $131.8 million in 2024, then grew by 7.9% to $142.2 million in 2025, then dropped by 1.98% to $139.4 million in 2026.
• Per Business Quant, the three latest PRCT Total Liabilities figures stand at $139.4 million (Q1 2026), $142.2 million (Q4 2025), and $131.3 million (Q3 2025).

Peer Comparison